Selected research
Industry Research
Tissue Fixative Industry Research Report 2026
Market perspective
The global Tissue Fixative market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tissue Fixative is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tissue Fixative is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tissue Fixative is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tissue Fixative include Thermo Fisher Scientific, Liaoshiyuan Biomedical Technology, Leica Biosystems, Servicebio, Saiguo Biotechnology, Boster Biological Technology, Abcam, Leagene and Beyotime, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tissue Fixative market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tissue Fixative Market by Company
Thermo Fisher Scientific
Liaoshiyuan Biomedical Technology
Leica Biosystems
Servicebio
Saiguo Biotechnology
Boster Biological Technology
Abcam
Leagene
Beyotime
Sangon Biotech
Biosharp
Absin
Wako
Biotium
R&D Systems
Yeasen Biotechnology
Bestbio
Tissue Fixative Segment by Type
DEPC-free
DEPC-containing
Tissue Fixative Segment by Application
Immunohistochemistry
Immunocytochemistry
Other
Tissue Fixative Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue Fixative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue Fixative and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue Fixative.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tissue Fixative manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tissue Fixative by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tissue Fixative in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DEPC-free
- DEPC-containing
Applications
- Immunohistochemistry
- Immunocytochemistry
- Other
Companies covered
- Thermo Fisher Scientific
- Liaoshiyuan Biomedical Technology
- Leica Biosystems
- Servicebio
- Saiguo Biotechnology
- Boster Biological Technology
- Abcam
- Leagene
- Beyotime
- Sangon Biotech
- Biosharp
- Absin
- Wako
- Biotium
- R&D Systems
- Yeasen Biotechnology
- Bestbio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tissue Fixative Market Size (2021-2032)
- 2.2.2 Global Tissue Fixative Sales (2021-2032)
- 2.2.3 Global Tissue Fixative Market Average Price (2021-2032)
- 2.3 Tissue Fixative by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 DEPC-free
- 2.3.3 DEPC-containing
- 2.4 Tissue Fixative by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Immunohistochemistry
- 2.4.3 Immunocytochemistry
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tissue Fixative Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tissue Fixative Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Tissue Fixative Revenue of Manufacturers (2021-2026)
- 3.4 Global Tissue Fixative Average Price by Manufacturers (2021-2026)
- 3.5 Global Tissue Fixative Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tissue Fixative, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tissue Fixative, Product Type & Application
- 3.8 Global Manufacturers of Tissue Fixative, Established Date
- 3.9 Global Tissue Fixative Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Tissue Fixative Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Liaoshiyuan Biomedical Technology
- 4.2.1 Liaoshiyuan Biomedical Technology Company Information
- 4.2.2 Liaoshiyuan Biomedical Technology Business Overview
- 4.2.3 Liaoshiyuan Biomedical Technology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Liaoshiyuan Biomedical Technology Tissue Fixative Product Portfolio
- 4.2.5 Liaoshiyuan Biomedical Technology Recent Developments
- 4.3 Leica Biosystems
- 4.3.1 Leica Biosystems Company Information
- 4.3.2 Leica Biosystems Business Overview
- 4.3.3 Leica Biosystems Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Leica Biosystems Tissue Fixative Product Portfolio
- 4.3.5 Leica Biosystems Recent Developments
- 4.4 Servicebio
- 4.4.1 Servicebio Company Information
- 4.4.2 Servicebio Business Overview
- 4.4.3 Servicebio Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Servicebio Tissue Fixative Product Portfolio
- 4.4.5 Servicebio Recent Developments
- 4.5 Saiguo Biotechnology
- 4.5.1 Saiguo Biotechnology Company Information
- 4.5.2 Saiguo Biotechnology Business Overview
- 4.5.3 Saiguo Biotechnology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Saiguo Biotechnology Tissue Fixative Product Portfolio
- 4.5.5 Saiguo Biotechnology Recent Developments
- 4.6 Boster Biological Technology
- 4.6.1 Boster Biological Technology Company Information
- 4.6.2 Boster Biological Technology Business Overview
- 4.6.3 Boster Biological Technology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Boster Biological Technology Tissue Fixative Product Portfolio
- 4.6.5 Boster Biological Technology Recent Developments
- 4.7 Abcam
- 4.7.1 Abcam Company Information
- 4.7.2 Abcam Business Overview
- 4.7.3 Abcam Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Abcam Tissue Fixative Product Portfolio
- 4.7.5 Abcam Recent Developments
- 4.8 Leagene
- 4.8.1 Leagene Company Information
- 4.8.2 Leagene Business Overview
- 4.8.3 Leagene Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Leagene Tissue Fixative Product Portfolio
- 4.8.5 Leagene Recent Developments
- 4.9 Beyotime
- 4.9.1 Beyotime Company Information
- 4.9.2 Beyotime Business Overview
- 4.9.3 Beyotime Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Beyotime Tissue Fixative Product Portfolio
- 4.9.5 Beyotime Recent Developments
- 4.10 Sangon Biotech
- 4.10.1 Sangon Biotech Company Information
- 4.10.2 Sangon Biotech Business Overview
- 4.10.3 Sangon Biotech Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sangon Biotech Tissue Fixative Product Portfolio
- 4.10.5 Sangon Biotech Recent Developments
- 4.11 Biosharp
- 4.11.1 Biosharp Company Information
- 4.11.2 Biosharp Business Overview
- 4.11.3 Biosharp Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Biosharp Tissue Fixative Product Portfolio
- 4.11.5 Biosharp Recent Developments
- 4.12 Absin
- 4.12.1 Absin Company Information
- 4.12.2 Absin Business Overview
- 4.12.3 Absin Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Absin Tissue Fixative Product Portfolio
- 4.12.5 Absin Recent Developments
- 4.13 Wako
- 4.13.1 Wako Company Information
- 4.13.2 Wako Business Overview
- 4.13.3 Wako Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Wako Tissue Fixative Product Portfolio
- 4.13.5 Wako Recent Developments
- 4.14 Biotium
- 4.14.1 Biotium Company Information
- 4.14.2 Biotium Business Overview
- 4.14.3 Biotium Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Biotium Tissue Fixative Product Portfolio
- 4.14.5 Biotium Recent Developments
- 4.15 R&D Systems
- 4.15.1 R&D Systems Company Information
- 4.15.2 R&D Systems Business Overview
- 4.15.3 R&D Systems Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 R&D Systems Tissue Fixative Product Portfolio
- 4.15.5 R&D Systems Recent Developments
- 4.16 Yeasen Biotechnology
- 4.16.1 Yeasen Biotechnology Company Information
- 4.16.2 Yeasen Biotechnology Business Overview
- 4.16.3 Yeasen Biotechnology Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Yeasen Biotechnology Tissue Fixative Product Portfolio
- 4.16.5 Yeasen Biotechnology Recent Developments
- 4.17 Bestbio
- 4.17.1 Bestbio Company Information
- 4.17.2 Bestbio Business Overview
- 4.17.3 Bestbio Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Bestbio Tissue Fixative Product Portfolio
- 4.17.5 Bestbio Recent Developments
5 Global Tissue Fixative Market Scenario by Region
- 5.1 Global Tissue Fixative Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tissue Fixative Sales by Region: 2021-2032
- 5.2.1 Global Tissue Fixative Sales by Region: 2021-2026
- 5.2.2 Global Tissue Fixative Sales by Region: 2027-2032
- 5.3 Global Tissue Fixative Revenue by Region: 2021-2032
- 5.3.1 Global Tissue Fixative Revenue by Region: 2021-2026
- 5.3.2 Global Tissue Fixative Revenue by Region: 2027-2032
- 5.4 North America Tissue Fixative Market Facts & Figures by Country
- 5.4.1 North America Tissue Fixative Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tissue Fixative Sales by Country (2021-2032)
- 5.4.3 North America Tissue Fixative Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Tissue Fixative Market Facts & Figures by Country
- 5.5.1 Europe Tissue Fixative Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tissue Fixative Sales by Country (2021-2032)
- 5.5.3 Europe Tissue Fixative Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Tissue Fixative Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tissue Fixative Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tissue Fixative Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tissue Fixative Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tissue Fixative Market Facts & Figures by Country
- 5.7.1 South America Tissue Fixative Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tissue Fixative Sales by Country (2021-2032)
- 5.7.3 South America Tissue Fixative Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Tissue Fixative Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tissue Fixative Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tissue Fixative Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tissue Fixative Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Tissue Fixative Sales by Type (2021-2032)
- 6.1.1 Global Tissue Fixative Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Tissue Fixative Sales Market Share by Type (2021-2032)
- 6.2 Global Tissue Fixative Revenue by Type (2021-2032)
- 6.2.1 Global Tissue Fixative Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tissue Fixative Revenue Market Share by Type (2021-2032)
- 6.3 Global Tissue Fixative Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tissue Fixative Sales by Application (2021-2032)
- 7.1.1 Global Tissue Fixative Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Tissue Fixative Sales Market Share by Application (2021-2032)
- 7.2 Global Tissue Fixative Revenue by Application (2021-2032)
- 7.2.1 Global Tissue Fixative Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tissue Fixative Revenue Market Share by Application (2021-2032)
- 7.3 Global Tissue Fixative Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tissue Fixative Value Chain Analysis
- 8.1.1 Tissue Fixative Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tissue Fixative Production Mode & Process
- 8.2 Tissue Fixative Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tissue Fixative Distributors
- 8.2.3 Tissue Fixative Customers
9 Global Tissue Fixative Analyzing Market Dynamics
- 9.1 Tissue Fixative Industry Trends
- 9.2 Tissue Fixative Industry Drivers
- 9.3 Tissue Fixative Industry Opportunities and Challenges
- 9.4 Tissue Fixative Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst